We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
(+5.3%)
Cap. Flow
+$328M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$454M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$312M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$286M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$248M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$829M |
| 2 |
MIME
Mimecast Limited
MIME
|
+$351M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$325M |
| 4 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$260M |
| 5 |
VNE
Veoneer, Inc.
VNE
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 20.95% |
| 3 | Industrials | 11.05% |
| 4 | Real Estate | 10.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
REVH
151
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $6.65M | 0.07% |
681,302
| – | – |
2021 Q2
4 quarters
|
|
|
TMAC
152
DELISTED
The Music Acquisition Corporation
TMAC
| $6.52M | 0.07% |
664,853
| – | – |
2021 Q1
5 quarters
|
|
|
SUAC
153
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
| $6.51M | 0.07% |
656,279
| – | – |
2022 Q1
1 quarter
|
|
154
Plug Power
PLUG
$2.35B
| $6.39M | 0.07% |
385,769
+320,769
| +493% | +$6.36M |
2021 Q1
5 quarters
|
|
|
BOAC
155
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $6.34M | 0.07% |
640,218
| – | – |
2020 Q4
6 quarters
|
|
|
HZNP
156
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.33M | 0.07% |
79,347
+54,347
| +217% | +$5.15M |
2022 Q1
1 quarter
|
|
|
ENTF
157
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
| $6.32M | 0.07% |
630,027
| – | – |
2021 Q4
2 quarters
|
|
158
KE Holdings
BEKE
$19.6B
| $6.26M | 0.07% |
348,824
+169,148
| +94% | +$2.38M |
2022 Q1
1 quarter
|
|
|
JUN
159
DELISTED
Juniper II Corp.
JUN
| $6.26M | 0.07% |
630,027
| – | – |
2022 Q1
1 quarter
|
|
|
CIIG
160
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
| $6.24M | 0.06% |
630,027
| – | – |
2021 Q4
2 quarters
|
|
161
SBA Communications
SBAC
$19.4B
| $6.23M | 0.06% |
19,471
+1,540
| +9% | +$519K |
2019 Q4
10 quarters
|
|
|
FTCV
162
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
| $6.22M | 0.06% |
631,970
| – | – |
2022 Q1
1 quarter
|
|
163
Chemours
CC
$2.05B
| $6.2M | 0.06% |
193,494
-167,624
| -46% | -$6.17M |
2020 Q4
6 quarters
|
|
164
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
| $6.18M | 0.06% |
617,698
| – | – |
2022 Q1
1 quarter
|
|
165
Choice Hotels
CHH
$4.75B
| $6.15M | 0.06% |
55,127
+37,727
| +217% | +$4.9M |
2022 Q1
1 quarter
|
|
166
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
| $6.15M | 0.06% |
630,027
| – | – |
2022 Q1
1 quarter
|
|
|
CFIV
167
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $6.12M | 0.06% |
621,404
| – | – |
2021 Q2
4 quarters
|
|
|
SCLE
168
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $6.09M | 0.06% |
620,646
| – | – |
2021 Q2
4 quarters
|
|
|
AUS
169
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $6.08M | 0.06% |
623,868
| – | – |
2021 Q2
4 quarters
|
|
|
ACRO
170
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
| $6.07M | 0.06% |
627,972
| – | – |
2021 Q3
3 quarters
|
|
171
DELISTED
Cartesian Growth Corporation II Unit
RENEU
| $6.07M | 0.06% |
+606,691
| New | +$6.06M |
2022 Q2
0 quarters
|
|
|
ANAC
172
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $5.99M | 0.06% |
609,531
+86,100
| +16% | +$844K |
2021 Q2
4 quarters
|
|
173
TriSalus Life Sciences
TLSI
$250M
| $5.97M | 0.06% |
606,691
| – | – |
2022 Q1
1 quarter
|
|
174
Healthpeak Properties
DOC
$13B
| $5.96M | 0.06% |
230,185
+175,610
| +322% | +$5.32M |
2022 Q1
1 quarter
|
|
175
MasTec
MTZ
$17.1B
| $5.95M | 0.06% |
83,028
-67,539
| -45% | -$5.27M |
2020 Q4
6 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2022 Portfolio in Review
As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.
- UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
- UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
- UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
- UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
- UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
- UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
- UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.